blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1910308

EP1910308 - IMIDAZOLE BASED LXR MODULATORS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  10.07.2015
Database last updated on 26.07.2024
Most recent event   Tooltip13.10.2017Lapse of the patent in a contracting state
New state(s): BG, HU, TR		published on 15.11.2017  [2017/46]
Applicant(s)For all designated states
Exelixis Patent Company LLC
210 East Grand Avenue
South San Francisco, CA 94080 / US
[2011/47]
Former [2008/16]For all designated states
Exelixis, Inc.
210 East Grand Avenue P.O. Box 511
South San Francisco, CA 94083-0511 / US
Inventor(s)01 / BUSCH, Brett B.
7523 Mona Lane
San Diego, CA 92130 / US
02 / FLATT, Brenton T.
12721 Pedriza Drive
Poway, CA 92064 / US
03 / GU, Xiao-Hui
7699 Palmilla Drive, 3408
San Diego, CA 92122 / US
04 / LU, Shao-Po
11693 Ramsdell Court
San Diego, CA 92131 / US
05 / MARTIN, Richard
4293 Cordobes Cove
San Diego, CA 92130 / US
06 / MOHAN, Raju
3125 Caminito Ricardo
Encinitas, CA 92024 / US
07 / NYMAN, Michael Charles
4511 Rhode Island Street
San Diego, CA 92116 / US
08 / SCHWEIGER, Edwin
4703 Vereda Luz Del Sol
San Diego, CA 92130 / US
09 / STEVENS, William C., Jr.
11632 Candy Rose Way
San Diego, CA 92131 / US
10 / WANG, Tie-Lin
7746 Roan Road
San Diego, CA 92129 / US
11 / XIE, Yinong
9669 Gold Coast Drive, 31
San Diego, CA 92126 / US
 [2008/16]
Representative(s)Main, Malcolm Charles, et al
Murgitroyd & Company
Scotland House
165-169 Scotland Street
Glasgow G5 8PL / GB
[2014/36]
Former [2008/16]Main, Malcolm Charles, et al
Murgitroyd & Company Scotland House 165-169 Scotland Street
Glasgow G5 8PL / GB
Application number, filing date06785562.726.06.2006
[2008/16]
WO2006US24757
Priority number, dateUS20050694372P27.06.2005         Original published format: US 694372 P
US20050736120P10.11.2005         Original published format: US 736120 P
[2008/16]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2007002563
Date:04.01.2007
Language:EN
[2007/01]
Type: A1 Application with search report 
No.:EP1910308
Date:16.04.2008
Language:EN
The application published by WIPO in one of the EPO official languages on 04.01.2007 takes the place of the publication of the European patent application.
[2008/16]
Type: B1 Patent specification 
No.:EP1910308
Date:03.09.2014
Language:EN
[2014/36]
Search report(s)International search report - published on:EP04.01.2007
ClassificationIPC:C07D233/54, C07D409/04, C07D401/04, A61K31/4164, A61P3/10
[2008/16]
CPC:
C07D233/64 (EP,KR,US); A61P1/16 (EP); A61P17/00 (EP);
A61P17/10 (EP); A61P25/00 (EP); A61P25/16 (EP);
A61P25/28 (EP); A61P29/00 (EP); A61P3/00 (EP);
A61P3/04 (EP); A61P3/06 (EP); A61P3/10 (EP);
A61P35/00 (EP); A61P37/00 (EP); A61P37/02 (EP);
A61P43/00 (EP); A61P9/00 (EP); A61P9/10 (EP);
C07D231/12 (EP,US); C07D231/22 (EP,US); C07D233/68 (KR);
C07D233/90 (EP,US); C07D401/04 (EP,US); C07D401/10 (EP,US);
C07D401/12 (EP,US); C07D401/14 (EP,US); C07D403/04 (EP,US);
C07D403/10 (EP,US); C07D403/12 (EP,US); C07D403/14 (EP,US);
C07D405/10 (EP,US); C07D405/12 (EP,US); C07D405/14 (EP,US);
C07D409/04 (EP,KR,US); C07D409/10 (EP,US); C07D409/12 (EP,US);
C07D409/14 (EP,KR,US); C07D413/12 (EP,US); C07D417/10 (EP,US);
C07D417/12 (EP,US); C07D417/14 (EP,US); C07D487/08 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/16]
Extension statesAL22.01.2008
BA22.01.2008
HR22.01.2008
MK22.01.2008
RS22.01.2008
TitleGerman:LXR-MODULATOREN AUF IMIDAZOLBASIS[2008/16]
English:IMIDAZOLE BASED LXR MODULATORS[2008/16]
French:RÉGULATEURS DE LXR DE TYPE IMIDAZOLE[2008/16]
Entry into regional phase22.01.2008National basic fee paid 
22.01.2008Designation fee(s) paid 
22.01.2008Examination fee paid 
Examination procedure22.01.2008Amendment by applicant (claims and/or description)
22.01.2008Examination requested  [2008/16]
21.05.2012Despatch of a communication from the examining division (Time limit: M04)
28.09.2012Reply to a communication from the examining division
10.10.2012Despatch of a communication from the examining division (Time limit: M04)
17.01.2013Reply to a communication from the examining division
16.10.2013Despatch of a communication from the examining division (Time limit: M04)
20.02.2014Reply to a communication from the examining division
10.04.2014Communication of intention to grant the patent
25.07.2014Fee for grant paid
25.07.2014Fee for publishing/printing paid
25.07.2014Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  21.05.2012
Opposition(s)04.06.2015No opposition filed within time limit [2015/33]
Fees paidRenewal fee
28.03.2008Renewal fee patent year 03
16.06.2009Renewal fee patent year 04
11.06.2010Renewal fee patent year 05
13.06.2011Renewal fee patent year 06
24.05.2012Renewal fee patent year 07
10.06.2013Renewal fee patent year 08
12.06.2014Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU26.06.2006
AT03.09.2014
BE03.09.2014
BG03.09.2014
CY03.09.2014
CZ03.09.2014
DK03.09.2014
EE03.09.2014
FI03.09.2014
LT03.09.2014
LV03.09.2014
MC03.09.2014
NL03.09.2014
PL03.09.2014
RO03.09.2014
SE03.09.2014
SI03.09.2014
SK03.09.2014
TR03.09.2014
GR04.12.2014
IS03.01.2015
PT05.01.2015
[2017/39]
Former [2016/33]AT03.09.2014
BE03.09.2014
CY03.09.2014
CZ03.09.2014
DK03.09.2014
EE03.09.2014
FI03.09.2014
LT03.09.2014
LV03.09.2014
MC03.09.2014
NL03.09.2014
PL03.09.2014
RO03.09.2014
SE03.09.2014
SI03.09.2014
SK03.09.2014
GR04.12.2014
IS03.01.2015
PT05.01.2015
Former [2016/09]AT03.09.2014
CY03.09.2014
CZ03.09.2014
DK03.09.2014
EE03.09.2014
FI03.09.2014
LT03.09.2014
LV03.09.2014
MC03.09.2014
NL03.09.2014
PL03.09.2014
RO03.09.2014
SE03.09.2014
SI03.09.2014
SK03.09.2014
GR04.12.2014
IS03.01.2015
PT05.01.2015
Former [2015/50]AT03.09.2014
CY03.09.2014
CZ03.09.2014
DK03.09.2014
EE03.09.2014
FI03.09.2014
LT03.09.2014
LV03.09.2014
NL03.09.2014
PL03.09.2014
RO03.09.2014
SE03.09.2014
SI03.09.2014
SK03.09.2014
GR04.12.2014
IS03.01.2015
PT05.01.2015
Former [2015/34]AT03.09.2014
CY03.09.2014
CZ03.09.2014
DK03.09.2014
EE03.09.2014
FI03.09.2014
LT03.09.2014
LV03.09.2014
NL03.09.2014
PL03.09.2014
RO03.09.2014
SE03.09.2014
SK03.09.2014
GR04.12.2014
IS03.01.2015
PT05.01.2015
Former [2015/24]AT03.09.2014
CY03.09.2014
CZ03.09.2014
EE03.09.2014
FI03.09.2014
LT03.09.2014
LV03.09.2014
NL03.09.2014
PL03.09.2014
RO03.09.2014
SE03.09.2014
SK03.09.2014
GR04.12.2014
IS03.01.2015
PT05.01.2015
Former [2015/23]AT03.09.2014
CY03.09.2014
CZ03.09.2014
EE03.09.2014
FI03.09.2014
LT03.09.2014
LV03.09.2014
NL03.09.2014
RO03.09.2014
SE03.09.2014
SK03.09.2014
GR04.12.2014
IS03.01.2015
PT05.01.2015
Former [2015/22]AT03.09.2014
CY03.09.2014
FI03.09.2014
LT03.09.2014
LV03.09.2014
NL03.09.2014
RO03.09.2014
SE03.09.2014
GR04.12.2014
PT05.01.2015
Former [2015/16]AT03.09.2014
CY03.09.2014
FI03.09.2014
LT03.09.2014
LV03.09.2014
NL03.09.2014
SE03.09.2014
GR04.12.2014
Former [2015/12]AT03.09.2014
CY03.09.2014
FI03.09.2014
LT03.09.2014
LV03.09.2014
SE03.09.2014
GR04.12.2014
Former [2015/11]CY03.09.2014
FI03.09.2014
LT03.09.2014
SE03.09.2014
GR04.12.2014
Former [2015/09]FI03.09.2014
LT03.09.2014
SE03.09.2014
Former [2015/08]LT03.09.2014
Cited inInternational search[X]EP0839810  (RHONE POULENC AGROCHIMIE [FR]) [X] 1-140 * example - *;
 [X]WO2004011446  (BAYER PHARMACEUTICALS CORP [US], et al) [X] 1-141 * example - *;
 [X]US2004157883  (CHEN CHIUNG-TONG [TW], et al) [X] 141 * example - *;
 [X]WO2004071447  (TRANSTECH PHARMA INC [US], et al) [X] 1-141 * example - *;
 [X]WO2004106307  (SOD CONSEILS RECH APPLIC [FR], et al) [X] 1-141 * example - *;
 [X]WO2005012263  (PHARMAGENE LAB LTD [GB], et al) [X] 1-141 * example - *;
 [X]WO2005047266  (LORUS THERAPEUTICS INC [CA], et al) [X] 1-141 * example - *;
 [PX]WO2005066137  (NEUROGEN CORP [US], et al) [PX] 1-141 * example - *;
 [E]WO2006076202  (EXELIXIS INC [US], et al) [E] 1-144* the whole document *;
 [A]  - BENNETT ET AL, "Liver X receptor agonist as a treatment for atherosclerosis", EXPERT OPINION ON THERAPEUTIC PATENTS, ASHLEY PUBLICATIONS, GB, (2004), vol. 14, no. 7, ISSN 1354-3776, pages 967 - 982, XP002342352 [A] 1-144 * the whole document *

DOI:   http://dx.doi.org/10.1517/13543776.14.7.967
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.